BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28295259)

  • 1. Applying the TOR(C)QUE in iNKT cells: A new twist in an old tale.
    Verykokakis M; Kee BL
    Eur J Immunol; 2017 Mar; 47(3):454-457. PubMed ID: 28295259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutting edge: Discrete functions of mTOR signaling in invariant NKT cell development and NKT17 fate decision.
    Wei J; Yang K; Chi H
    J Immunol; 2014 Nov; 193(9):4297-4301. PubMed ID: 25261481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammalian target of rapamycin complex 2 regulates invariant NKT cell development and function independent of promyelocytic leukemia zinc-finger.
    Prevot N; Pyaram K; Bischoff E; Sen JM; Powell JD; Chang CH
    J Immunol; 2015 Jan; 194(1):223-30. PubMed ID: 25404366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mTORC2 regulates multiple aspects of NKT-cell development and function.
    Sklarz T; Guan P; Gohil M; Cotton RM; Ge MQ; Haczku A; Das R; Jordan MS
    Eur J Immunol; 2017 Mar; 47(3):516-526. PubMed ID: 28078715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammalian target of rapamycin complex 1 orchestrates invariant NKT cell differentiation and effector function.
    Zhang L; Tschumi BO; Corgnac S; Rüegg MA; Hall MN; Mach JP; Romero P; Donda A
    J Immunol; 2014 Aug; 193(4):1759-65. PubMed ID: 25015820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mTOR and its tight regulation for iNKT cell development and effector function.
    Yang W; Gorentla B; Zhong XP; Shin J
    Mol Immunol; 2015 Dec; 68(2 Pt C):536-45. PubMed ID: 26253278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKAP Regulates Invariant NKT Cell Proliferation and Differentiation into ROR-γt-Expressing NKT17 Cells.
    Thapa P; Chen MW; McWilliams DC; Belmonte P; Constans M; Sant'Angelo DB; Shapiro VS
    J Immunol; 2016 Jun; 196(12):4987-98. PubMed ID: 27183586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ly9 (SLAMF3) receptor differentially regulates iNKT cell development and activation in mice.
    Cuenca M; Puñet-Ortiz J; Ruart M; Terhorst C; Engel P
    Eur J Immunol; 2018 Jan; 48(1):99-105. PubMed ID: 28980301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Timing and Abundance of IL-2Rβ (CD122) Expression Control Thymic
    Won HY; Kim HK; Crossman A; Awasthi P; Gress RE; Park JH
    Front Immunol; 2021; 12():642856. PubMed ID: 34054809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uhrf1 Controls iNKT Cell Survival and Differentiation through the Akt-mTOR Axis.
    Cui Y; Chen X; Zhang J; Sun X; Liu H; Bai L; Xu C; Liu X
    Cell Rep; 2016 Apr; 15(2):256-63. PubMed ID: 27050515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic target of rapamycin complex 1 is critical for invariant natural killer T-cell development and effector function.
    Shin J; Wang S; Deng W; Wu J; Gao J; Zhong XP
    Proc Natl Acad Sci U S A; 2014 Feb; 111(8):E776-83. PubMed ID: 24516149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential dependence on nuclear factor-κB-inducing kinase among natural killer T-cell subsets in their development.
    Noma H; Eshima K; Satoh M; Iwabuchi K
    Immunology; 2015 Sep; 146(1):89-99. PubMed ID: 25988531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unveiling the regulation of NKT17 cell differentiation and function.
    Tsagaratou A
    Mol Immunol; 2019 Jan; 105():55-61. PubMed ID: 30496977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. iNKT cells require TSC1 for terminal maturation and effector lineage fate decisions.
    Wu J; Yang J; Yang K; Wang H; Gorentla B; Shin J; Qiu Y; Que LG; Foster WM; Xia Z; Chi H; Zhong XP
    J Clin Invest; 2014 Apr; 124(4):1685-98. PubMed ID: 24614103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptome and chromatin landscape of iNKT cells are shaped by subset differentiation and antigen exposure.
    Murray MP; Engel I; Seumois G; Herrera-De la Mata S; Rosales SL; Sethi A; Logandha Ramamoorthy Premlal A; Seo GY; Greenbaum J; Vijayanand P; Scott-Browne JP; Kronenberg M
    Nat Commun; 2021 Mar; 12(1):1446. PubMed ID: 33664261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transcription factor lymphoid enhancer factor 1 controls invariant natural killer T cell expansion and Th2-type effector differentiation.
    Carr T; Krishnamoorthy V; Yu S; Xue HH; Kee BL; Verykokakis M
    J Exp Med; 2015 May; 212(5):793-807. PubMed ID: 25897173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invariant NKT cells require autophagy to coordinate proliferation and survival signals during differentiation.
    Pei B; Zhao M; Miller BC; Véla JL; Bruinsma MW; Virgin HW; Kronenberg M
    J Immunol; 2015 Jun; 194(12):5872-84. PubMed ID: 25926673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathymic proliferation wave essential for Valpha14+ natural killer T cell development depends on c-Myc.
    Dose M; Sleckman BP; Han J; Bredemeyer AL; Bendelac A; Gounari F
    Proc Natl Acad Sci U S A; 2009 May; 106(21):8641-6. PubMed ID: 19423665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-Catenin is required for the differentiation of iNKT2 and iNKT17 cells that augment IL-25-dependent lung inflammation.
    Berga-Bolaños R; Sharma A; Steinke FC; Pyaram K; Kim YH; Sultana DA; Fang JX; Chang CH; Xue HH; Heller NM; Sen JM
    BMC Immunol; 2015 Oct; 16():62. PubMed ID: 26482437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syndecan-1 identifies and controls the frequency of IL-17-producing naïve natural killer T (NKT17) cells in mice.
    Dai H; Rahman A; Saxena A; Jaiswal AK; Mohamood A; Ramirez L; Noel S; Rabb H; Jie C; Hamad AR
    Eur J Immunol; 2015 Nov; 45(11):3045-51. PubMed ID: 26300525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.